EULAR 2020 | e-congress Satellite symposia

A number of satellite symposia virtual events will be organised during EULAR 2020 E-CONGRESS from 3 June 2020. 

The Satellite symposia programme is online. Sessions are added following approval

Link to programme

 

Satellite symposia are governed by EULAR Guidelines. Symposia are strictly prohibited during the official programme hours. All symposia and special events must be approved by EULAR.


Satellite Symposia Progamme 2020

June 03  |  18:15 - 19:30 CEST
Janssen | Advancing the treatment of PsA: focus on the IL-23 pathway
Speaker(s): Various
Session details

June 03  |  18:15 - 19:45 CEST
Amgen | A collaborative and personalized approach to early and moderate PsA
Chair: PD Dr. med. Frank Behrens, Germany
Session details

June 03  |  18:15 - 19:45 CEST
AbbVie | The New Normal? A Practical Guide to Telemedicine in Rheumatology
Speaker(s): Various
Session details

June 03  |  18:15 - 19:45 CEST
AstraZeneca | Recent progress in the understanding and management of systemic lupus erythematosus
Speaker(s): Various
Session details

June 03  |  18:15 - 19:55 CEST
Vifor Pharma | Insights into the mechanism of disease and unmet needs in ANCA-associated vasculitis
Speaker(s): Various
Session details

 


June 04  |  08:15 - 09:15 CEST
Roche | Turning the pages for GCA patients: Targeted therapy
Chair: Prof. Bernhard Hellmich, Germany
Session details

June 04  |  08:15 - 09:45 CEST
Novartis | Reimagining Axial SpA: Clinical Priorities
Chair: Prof. Robert B.M. Landewé, Netherlands
Session details

June 04  |  08:15 - 09:45 CEST
Gilead and Galapagos | In Darwin’s footsteps: adaptation through innovation in RA
Speaker(s): Various
Session details

June 04  |  08:15 - 09:45 CEST
Lilly | JAK inhibition for RA: A paradigm shift reality
Chairs: Dr. Bernard Combe, France, Prof. Ulf Müller-Ladner, Germany
Session details

June 04  |  08:15 - 09:45 CEST
Medac | Optimizing methotrexate treatment to improve first-line therapy 
Chairs: Prof. Christoph Fiehn, Germany
Session details

June 04  |  08:15 - 09:45 CEST
Samsung Bioepis and Biogen | Treatment Journey with Rheumatoid Arthritis: From Diagnosis to Disease Control
Chair: Prof. Dr. Josef S. Smolen, Austria
Session details

June 04  |  08:15 - 09:45 CEST
Sanofi Genzyme | Extending Your Interdisciplinary Understanding of IL-6R Inhibitors in Rheumatoid Arthritis
Chair: Dr. Christof Specker, Germany
Session details

June 04  |  17:30 - 18:30 CEST
Pfizer | JAK Inhibitors for the Treatment of Patients With Rheumatoid Arthritis (RA): Learnings from Real World Experience
Speaker(s): Various
Session details

June 04  |  17:30 - 18:45 CEST
GSK | Following the science in SLE: from guidelines to practice
Chair: Prof. Dr. Andreas Schwarting, Germany
Session details

June 04  |  17:30 - 19:00 CEST
UCB | Raising the Bar for Optimal Management of Axial Spondyloarthritis
Speaker(s): Various
Session details

June 04  |  17:30 - 19:15 CEST
AbbVie | The next chapter in SpA management: JAK inhibitors
Speaker(s): Various
Session details

June 04  |  17:30 - 19:00 CEST
Lilly | Emerging learnings in Spondyloarthritis (SpA): From clinical trials to clinical practice
Chair: Prof. Joachim Sieper, Germany
Session details

June 04  |  17:30 - 19:00 CEST
Celltrion Healthcare | Beyond current treatment options: Infliximab SC
Speaker(s): Various
Session details

 


June 04  |  08:15 - 09:45 CEST
Novartis | Reimagining PsA: Raising the standard of care for patients​
Chair: Prof. Désirée van der Heijde, Netherlands
Session details

June 05  |  08:15 - 09:45 CEST
Vifor Pharma | Can outcomes in ANCA Associated Vasculitis be improved by targeting disease mechanisms?
Chair: Prof. Peter Lamprecht, Germany
Session details

June 05  |  08:15 - 09:45 CEST
Boehringer Ingelheim | Towards a better understanding of interstitial lung diseases associated with autoimmune rheumatic diseases
Chair: Prof. Marco Matucci-Cerinic, Italy
Session details

June 05  |  08:15 - 09:45 CEST
Fresenius Kabi | Adalimumab in the new decade
Chair: Prof. Peter C. Taylor, United Kingdom
Session details

June 05  |  08:15 - 09:15 CEST
Pfizer | JAK Inhibitors for the Treatment of Patients With Rheumatoid Arthritis (RA): Learnings from Real World Experience
Speaker(s): Various
Session details

June 05  |  08:15 - 09:45 CEST
BMS | Insights Into Seropositive Rheumatoid Arthritis: A Path Towards Precision Medicine
Chair: Prof. Dr. Gerd Rüdinger Burmester, Germany
Session details

June 05  |  17:30 - 19:46 CEST
GSK | Following the science in SLE: from guidelines to practice
Chair: Prof. Dr. Andreas Schwarting, Germany
Session details

June 05  |  17:30 - 18:30 CEST
UCB | PsA Treatment: Can We Achieve More For Our Patients?
Speaker(s): Various
Session details

June 05  |  17:30 - 19:00 CEST
Gilead and Galapagos | In Darwin’s footsteps: adaptation through innovation in RA
Chair: Prof. Dr. Georg Schett, Germany
Session details